Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
critical_drugs_coalition [2022/02/20 20:14]
liam [Membership]
critical_drugs_coalition [2022/02/21 09:15]
liam
Line 23: Line 23:
     * Co-founder and President of [[Canadian PKU & Allied Disorders]] (sponsored by [[pharmaceutical_companies:Biomarin]], [[pharmaceutical_companies:Vitaflo]], [[pharmaceutical_companies:Innovative Medicines Canada]], [[Pharmaceutical Research and Manufacturers of America]], [[pharmaceutical_companies:PTC Therapeutics]], and [[Canadian Red Cross]]);((//Sponsors.// Canadian PKU and Allied Disorders. Retrieved February 20, 2022, from https://canpku.org/Sponsors))     * Co-founder and President of [[Canadian PKU & Allied Disorders]] (sponsored by [[pharmaceutical_companies:Biomarin]], [[pharmaceutical_companies:Vitaflo]], [[pharmaceutical_companies:Innovative Medicines Canada]], [[Pharmaceutical Research and Manufacturers of America]], [[pharmaceutical_companies:PTC Therapeutics]], and [[Canadian Red Cross]]);((//Sponsors.// Canadian PKU and Allied Disorders. Retrieved February 20, 2022, from https://canpku.org/Sponsors))
     * Volunteer co-chair of the [[Disability Tax Fairness Alliance]];((Adams, J., & Weissman, P. (2021). //DTFA Budget 2021 Letter.// Fighting for Fairness. https://web.archive.org/web/20220220191051/http://www.fightingforfairness.ca/pdf/DTFABudget2021LettertMay3.pdf.pdf))     * Volunteer co-chair of the [[Disability Tax Fairness Alliance]];((Adams, J., & Weissman, P. (2021). //DTFA Budget 2021 Letter.// Fighting for Fairness. https://web.archive.org/web/20220220191051/http://www.fightingforfairness.ca/pdf/DTFABudget2021LettertMay3.pdf.pdf))
 +    * Past member of the Board of Directors of the [[Canadian Organization of Rare Disorders]];((//Experience - John Adams.// LinkedIn. Retrieved February 20, 2022, from https://www.linkedin.com/in/john-adams-1687239/details/experience/))
 +    * Former reporter for the [[Globe and Mail]];((//John Adams.// Facebook. Retrieved February 20, 2022, from https://archive.ph/Uwa3N))
 +    * Former Chief of Staff to the Ontario Minister of Community and Social Services;((//John Adams.// Facebook. Retrieved February 20, 2022, from https://archive.ph/Uwa3N))
 +    * Former Director of Marketing Services for the [[Urban Transportation Development Corporation]];((//Experience - John Adams.// LinkedIn. Retrieved February 20, 2022, from https://www.linkedin.com/in/john-adams-1687239/details/experience/))
 +    * Former Director of Government Relations for the [[Ontario Public School Boards' Association]];((//Experience - John Adams.// LinkedIn. Retrieved February 20, 2022, from https://www.linkedin.com/in/john-adams-1687239/details/experience/))
 +    * Former Councillor for the [[City of Toronto]];((//Experience - John Adams.// LinkedIn. Retrieved February 20, 2022, from https://www.linkedin.com/in/john-adams-1687239/details/experience/))
 +    * Global Director of Business Development for [[OZ Systems International]]((//John Adams.// Environmental Law & Regulation. Retrieved February 20, 2022, from https://archive.ph/aQc98))
 +    * Speaker with the [[Canadian Institute]].
  
   * [[Saad Ahmed]] is a physician and lecturer at the [[Scarborough Health Network]].   * [[Saad Ahmed]] is a physician and lecturer at the [[Scarborough Health Network]].
Line 29: Line 37:
  
   * [[Abdul Basith]] is an emergency physician at the [[Markham Stouffville Hospital]] at [[Oak Valley Health]], associated with the [[University of Toronto]].   * [[Abdul Basith]] is an emergency physician at the [[Markham Stouffville Hospital]] at [[Oak Valley Health]], associated with the [[University of Toronto]].
 +
 +  * [[Aman Chatha]] is:
 +    * Founder of [[Social Impact Agency]];((Aman Chatha (@amanchatha). //Founder SocialimpactAgency.com Founder GroupBuyUnited.com.// Twitter. Retrieved February 20, 2022, from https://twitter.com/amanchatha)) ((Hicks, D., Cliche, D., & Chatha, A. (2018). //Mapping The Customer Experience on The Path to Increased ROI.// https://web.archive.org/web/20220221080125/https://www.electrofed.com/wp-content/uploads/2018/11/David-Hicks-Connecting-with-the-Customer-Threat-or-Opportunity-Through-Mapping-the-Customer-Experience.pdf))
 +    * Founder of [[Group Buy United]]
 +    * Vice President of Innovation and Strategic Partnerships at [[The Marketing Department]] (TMD)
 +    * Leader of Corporate Partnerships & Sponsors at [[Conquer COVID-19]]
 +    * Senior Business Development Consultant at [[Cloud Dynamics Inc.]]
 +    * Senior Strategy & Business Development Consultant at [[Tench Labs]]
 +    * Various senior positions with [[Aon]]
 +    * Former teacher at [[Sheridan College]]
  
   * [[Ian Hilley]] is self-described as an “experienced pharmaceutical executive” and “effective advocate and lobbyist.”((Hilley, I. [@inhilleu]. //Experienced Pharmaceutical Executive, President Canadian Hemochromatosis Society- Canada’s #1 genetic disorder, involved in the health & wellness of seniors [Profile].// Accessed December 1, 2021. Twitter. https://twitter.com/inhilley)) He is President of [[Hilley Pharma Advisors]], President of the [[Canadian Hemochromatosis Society]], former Chair of [[Community and Home Assistance for Seniors]] (CHATS) and Member of the [[Royal Pharmaceutical Society of Great Britain]].((The Canadian Institute’s Pharma Symposium Canada. (2016, May). //Ian Hilley.// Retrieved December 1, 2021, from https://www.canadianinstitute.com/pharma-symposium-canada-350x16-tor/speakers/ian-hilley/)) Hilley’s CV also includes history of “providing strategic leadership and advice to clients to achieve their commercial goals in areas such as business development, engaging private payors, product development, market access and pricing.” Those positions include:   * [[Ian Hilley]] is self-described as an “experienced pharmaceutical executive” and “effective advocate and lobbyist.”((Hilley, I. [@inhilleu]. //Experienced Pharmaceutical Executive, President Canadian Hemochromatosis Society- Canada’s #1 genetic disorder, involved in the health & wellness of seniors [Profile].// Accessed December 1, 2021. Twitter. https://twitter.com/inhilley)) He is President of [[Hilley Pharma Advisors]], President of the [[Canadian Hemochromatosis Society]], former Chair of [[Community and Home Assistance for Seniors]] (CHATS) and Member of the [[Royal Pharmaceutical Society of Great Britain]].((The Canadian Institute’s Pharma Symposium Canada. (2016, May). //Ian Hilley.// Retrieved December 1, 2021, from https://www.canadianinstitute.com/pharma-symposium-canada-350x16-tor/speakers/ian-hilley/)) Hilley’s CV also includes history of “providing strategic leadership and advice to clients to achieve their commercial goals in areas such as business development, engaging private payors, product development, market access and pricing.” Those positions include:
Line 37: Line 55:
  
   * [[Amirpouyan Namavarian]] is a resident at the [[University of Toronto]]’s Department of Otolaryngology Head and Neck Surgery section.((Pouyan Namavarian, MD (@Namavarian). //Resident @UofT_OHNS . MD  @UofTMedicine . BMSc  @SchulichMedDent . Interests in #GlobalSurgery, #Politics, #MedTech, & #Raptors.// Twitter. Retrieved February 19, 2022, from https://twitter.com/Namavarian)) He began his postdoctoral training on July 1, 2021.((//Namavarian, Amirpouyan - Doctor Details.// College of Physicians and Surgeons of Ontario. Retrieved February 19, 2022, from https://archive.ph/237ve)) He served as a Research Assistant at University Hospital - [[London Health Sciences Centre]] (June 2016 - June 2017); [[Schulich School of Medicine & Dentistry]] (July 2016 - May 2017); [[Trillium Health Partners]] (January 2018 - January 2021); and [[Mount Sinai Hospital]] (June 2019 - August 2019).((//Amirpouyan Namavarian.// LinkedIn. Retrieved February 20, 2022, from https://archive.ph/VnVm6)) He previously completed his Bachelor of Sciences in Interdisciplinary Medical Science at the [[University of Western Ontario]], where he attended from 2012-2016.   * [[Amirpouyan Namavarian]] is a resident at the [[University of Toronto]]’s Department of Otolaryngology Head and Neck Surgery section.((Pouyan Namavarian, MD (@Namavarian). //Resident @UofT_OHNS . MD  @UofTMedicine . BMSc  @SchulichMedDent . Interests in #GlobalSurgery, #Politics, #MedTech, & #Raptors.// Twitter. Retrieved February 19, 2022, from https://twitter.com/Namavarian)) He began his postdoctoral training on July 1, 2021.((//Namavarian, Amirpouyan - Doctor Details.// College of Physicians and Surgeons of Ontario. Retrieved February 19, 2022, from https://archive.ph/237ve)) He served as a Research Assistant at University Hospital - [[London Health Sciences Centre]] (June 2016 - June 2017); [[Schulich School of Medicine & Dentistry]] (July 2016 - May 2017); [[Trillium Health Partners]] (January 2018 - January 2021); and [[Mount Sinai Hospital]] (June 2019 - August 2019).((//Amirpouyan Namavarian.// LinkedIn. Retrieved February 20, 2022, from https://archive.ph/VnVm6)) He previously completed his Bachelor of Sciences in Interdisciplinary Medical Science at the [[University of Western Ontario]], where he attended from 2012-2016.
 +
 +  * [[Rahil Shah]] is:((//Rahil Shah.// LinkedIn. Retrieved February 21, 2022, from https://www.linkedin.com/in/rahilllshah))
 +    * Design Technologist Intern at [[Shopify]]
 +    * Product Design Intern at [[Robinhood]], [[Meta]], and [[Twitch]]
 +    * Front-End Developer at the [[Schulich School of Medicine & Dentistry]]
 +    * Various roles, including Co-Director, at [[DeltaHacks]]
 +    * Product designer for [[CanTrace]], presented to the [[Government of Canada]]
 +    * Web Design Intern at [[Nova Solutions]]
 +    * Sponsorship Executive at [[McMaster University|McMaster Design League]]
  
   * [[Abdulwahab Sidiqi]] is a fourth-year medical student at the [[University of Toronto]]. He co-wrote the following articles strongly advocating for pharmaceutical products:   * [[Abdulwahab Sidiqi]] is a fourth-year medical student at the [[University of Toronto]]. He co-wrote the following articles strongly advocating for pharmaceutical products:
Back to top